316 related articles for article (PubMed ID: 8448558)
21. An Italian study comparing allogeneic and autologous BMT in childhood acute lymphoblastic leukemia using HD-vincristine, F-TBI and cyclophosphamide.
Uderzo C; Colleselli P; Dini G; Bonetti F; Andolina F; Bagnulo S; Miniero R; Rondelli R; Balduzzi A; Locasciulli A
Bone Marrow Transplant; 1991; 7 Suppl 3():19-21. PubMed ID: 1855081
[No Abstract] [Full Text] [Related]
22. Controversies on the role of bone marrow transplantation for patients with hematopoietic malignancies.
Geller RB
Mt Sinai J Med; 1994 Jan; 61(1):13-22. PubMed ID: 8183287
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow transplantation for chronic myeloid leukaemia.
Goldman JM
Bone Marrow Transplant; 1991; 7 Suppl 2():62-3. PubMed ID: 1878724
[No Abstract] [Full Text] [Related]
24. Ph-positive acute lymphoblastic leukemia after long-term remission of Ph-positive acute myeloid leukemia.
Nishida H; Yoshimizu N; Ueno H; Fujita A; Kato T; Park JW; Yano T; Tobinai K; Ikeda Y
Leuk Res; 2007 Mar; 31(3):417-8. PubMed ID: 16730062
[No Abstract] [Full Text] [Related]
25. Renal dysfunction after total-body irradiation. Significance of selective renal shielding blocks.
Igaki H; Karasawa K; Sakamaki H; Saito H; Nakagawa K; Ohtomo K; Tanaka Y
Strahlenther Onkol; 2005 Nov; 181(11):704-8. PubMed ID: 16254705
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
27. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
[TBL] [Abstract][Full Text] [Related]
28. Transplants in ALL.
Barrett AJ; Horowitz MM
Bone Marrow Transplant; 1992; 10 Suppl 1():30-6. PubMed ID: 1521088
[No Abstract] [Full Text] [Related]
29. Cultured epithelial allograft for the management of cutaneous graft-versus-host disease following stem-cell transplantation.
Milner SM; Cordova AC; Leffell M; Price LA
Transplantation; 2011 Nov; 92(9):e53-4. PubMed ID: 22027899
[No Abstract] [Full Text] [Related]
30. Acquired ichthyosis in bone marrow transplant recipients.
Spelman LJ; Strutton GM; Robertson IM; Weedon D
J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
[TBL] [Abstract][Full Text] [Related]
31. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1991; 12():327-46. PubMed ID: 1931449
[No Abstract] [Full Text] [Related]
32. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
[TBL] [Abstract][Full Text] [Related]
33. Total body irradiation dose and relapse risk after marrow transplantation for leukemia.
Frassoni F; Bacigalupo A; Marmont A; Scarpati D; Corvò R; Vitale V
Blood; 1991 Jun; 77(11):2543-4. PubMed ID: 2039837
[No Abstract] [Full Text] [Related]
34. Allogeneic bone marrow transplantation for ALL in Zagreb.
Bogdanić V; Labar B; Nemet D; Mrsić M; Pavetić Z; Aurer I
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():88-9. PubMed ID: 2697414
[No Abstract] [Full Text] [Related]
35. Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias.
Bernasconi C; Lazzarino M; Canevari A; Morra E; Castelli G; Brusamolino E; Alessandrino EP; Pagnucco G; Orlandi E; Castagnola C
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():65-8. PubMed ID: 2697439
[No Abstract] [Full Text] [Related]
36. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
[TBL] [Abstract][Full Text] [Related]
37. Management of childhood acute leukemias: present concepts.
Advani SH; Nair R
Indian Pediatr; 1993 May; 30(5):589-91. PubMed ID: 8282385
[No Abstract] [Full Text] [Related]
38. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
40. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
